Drugs / Gusperimus
Gusperimus
also known as
15-deoxyspergualin trihydrochloride · BMS-181173 · BMY-42215-1 · Gusperimus hydrochloride · GUSPERIMUS TRIHYDROCHLORIDE · NKT-01 · NSC-356894 · Spanidin
Trials 3 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT00709722 | Oct 2003 → Apr 2007 | lupus nephritis | Nippon Kayaku Co., Ltd. | Completed | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT00530075 | Dec 2003 → Feb 2006 | granulomatosis with polyangiitis | Nippon Kayaku Co., Ltd. | Completed | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT01446211 | Nov 2011 → Nov 2012 | granulomatosis with polyangiitis | Nordic Pharma SAS | Terminated | No outcome recorded |
Evidence & citations 11 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Gusperimus | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01446211 ↗ |
| Known as | 15-deoxyspergualin trihydrochloride | ChEMBL registry synonym — accepted as the source's own label CHEMBL406117 ↗ |
| Known as | BMS-181173 | ChEMBL registry synonym — accepted as the source's own label CHEMBL406117 ↗ |
| Known as | BMY-42215-1 | ChEMBL registry synonym — accepted as the source's own label CHEMBL406117 ↗ |
| Known as | Gusperimus hydrochloride | ChEMBL registry synonym — accepted as the source's own label CHEMBL406117 ↗ |
| Known as | GUSPERIMUS TRIHYDROCHLORIDE | ChEMBL registry synonym — accepted as the source's own label CHEMBL406117 ↗ |
| Known as | NKT-01 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00709722 ↗ |
| Known as | NSC-356894 | ChEMBL registry synonym — accepted as the source's own label CHEMBL406117 ↗ |
| Known as | Spanidin | ChEMBL registry synonym — accepted as the source's own label CHEMBL406117 ↗ |
| Modality | Small molecule | — CHEMBL406117 ↗ |
| Route | Subcutaneous | “self-administered by subcutaneous injection” NCT00530075 ↗ |